Meridian Bioscience Stock

Meridian Bioscience EBIT per Share

The EBIT per Share of Meridian Bioscience (VIVO) as of Jul 16, 2026 is 1.70 USD. In the previous year, EBIT per Share was 2.31 USD — a change of -26.36% (lower).

EBIT per Share

1.70USD

YoY

-26.36%

Last updated:

EBIT per Share of Meridian Bioscience is 2026 1.70 USD. EBIT per Share of Meridian Bioscience was 2025 2.31 USD. It decreases by -26.36% lower compared to the previous year.
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

EBIT per Share of Meridian Bioscience is 1.70 USD in 2026.

Access this data via the Eulerpool API

Income Statement — Meridian Bioscience

All Key Metrics — Meridian Bioscience